Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
61.7M
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
57.9M
-
Shares change
-
-6.64M
-
Total reported value, excl. options
-
$78.1M
-
Value change
-
-$217M
-
Put/Call ratio
-
0.05
-
Number of buys
-
72
-
Number of sells
-
-89
-
Price
-
$1.35
Significant Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) as of Q1 2025
194 filings reported holding PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q1 2025.
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.9M shares
of 61.7M outstanding shares and own 93.78% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (6M shares), Deep Track Capital, LP (5.4M shares), BlackRock, Inc. (5.24M shares), VANGUARD GROUP INC (3.33M shares), MORGAN STANLEY (3.05M shares), Cormorant Asset Management, LP (3M shares), Blue Owl Capital Holdings LP (2.97M shares), UBS Group AG (2.65M shares), Woodline Partners LP (2.51M shares), and TRV GP IV, LLC (2.13M shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.